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ABSTRAK
Tujuan dari penelitian ini adalah memanfaatkan antibodi poliklonal yang diproduksi dari kuda 
(Equus caballus) lokal Indonesia untuk membuat konjugat kit ELISA pendeteksi antigen permukaan 
virus hepatitis B (VHB; HBsAg). Antibodi poliklonal yang digunakan adalah dari kuda lokal yang 
diimunisasi berulang menggunakan HBsAg isolat Indonesia. Antibodi kemudian dikonjugasikan dengan 
enzim horseradish peroxidase dengan metode yang dimodifikasi dari Nakane dan Kawaoi. Uji aktivitas 
konjugat dilakukan dengan prinsip uji ELISA yang dikerjakan oleh peneliti dan juga oleh laboratorium 
independen. Sebagai pembanding, digunakan konjugat ELISA HBsAg komersial. Hasil penelitian ini 
menunjukkan bahwa antibodi yang diproduksi dari kuda lokal dapat digunakan untuk membuat konjugat 
dengan hasil yang sebanding dengan kit ELISA HBsAg komersial
Kata kunci: Kuda lokal, ELISA, antibodi poliklonal, hepatitis B, HBsAg
ABSTRACT
The aim of this study was to utilize the antibody produced using Indonesia local horses (Equus 
caballus) to make the conjugate of ELISA kit for detection of hepatitis B virus (HBV) surface antigen 
(HBsAg). The polyclonal antibodies were isolated and purified from local horses immunized repeatedly 
using isolated and purified HBsAg from Indonesia. The antibodies were conjugated with horseradish 
peroxidase by a modified method of Nakane and Kawaoi. The conjugate activities were performed using 
the principle of ELISA test conducted by the researchers as well as by independent laboratory. 
Commercial conjugate for HBsAg ELISA was used as a comparison study. The results of this study 
indicated that the antibody produced from local horses can be used to make conjugates that were 
comparable to commercial HBsAg ELISA kit.
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 INTRODUCTION
Up to now the hepatitis B virus (HBV) 
remains a major cause of world health problems 
as a cause of significant morbidity and mortality 
(Zukerman  and  Zukerman,  2000).  Around the 
world,   over   350   million   people   are   infected 
chronically with HBV, some of them will develop 
severe   liver   disease   including   cirrhosis   and 
hepatocellular carcinoma (Mulyanto et al., 2011, 
2012). The highest prevalence of HBV infection 
is generally found in Asia and Africa (Lee, 1997). 
In Indonesia the prevalence of HBV varies among 
the islands. It has been reported that HBV carrier 
rates among apparently healthy populations range 
from 4 to 20.3% (Khan et al., 2004; Mulyanto et 
al., 2008). Several efforts to prevent the spread of 
HBV have been conducted by the Indonesian 
government,   such   as   through   a   national 
vaccination   program   of   children   and   do   the 
screening of blood donors carried out by the 
Indonesian Red Cross. 
To perform the screening test, some standard 
test   kits   or   methods   such   as   enzyme-linked 
immunosorbent   assay   (ELISA)   are   required. 
Several standard test kits including ELISA are 
available in Indonesia. However, they mostly use 
components   that   are   imported   from   overseas 
which may lead to elevated production cost. To 
anticipate the growing need, as well as to reduce 
our   dependency   on   imported   products,   it   is 
necessary to develop an ELISA kit against HBV 
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Horse (Equus caballus) has long been used 
for   immunological   research   (Markel,   2007; 
Simon,   2007).   However   in   Indonesia   the 
utilization of local horses for diagnostic purposes 
is still limited. In this paper the results of the 
utilization   of   local   horses   as   a   source   of 
polyclonal antibodies against HBV, which were 
then used as raw materials to develop an ELISA 
conjugate, are reported. It is expected that the 
conjugate can be used for the development of 
ELISA kit for screening test of suspected samples 
being infected with HBV.
MATERIALS AND METHODS
Chemicals and Equipment
The enzyme horseradish peroxidase (HRP) 
Type VI-A (Lot No. 118 K 76701), ethylene 
glycol anhydrous 99.8% (Lot No. 0856AM), 1-
fluoro-2,4   dinitrobenzene   (FDNB;  Lot   No. 
0001451175), sodium meta-periodate (NaIO4; Lot 
No. MKBCB727), 3,3,’,55-Tetramethylbenzidine 
(TMB) Substrate (T4444 #089K1699), tween 20, 
BSA, were purchased from Sigma, USA, and 
sodium   borohydride   (NaBH4)   obtained   from 
Merck. Other chemicals such as NaCl, KH2PO4, 
were of analytical grade.
ELISA  plates   used   were   Microtiterwells, 
12x8 (break apart) strips, 96 wells (SLP). Optical 
density measurements were made on a Thermo 
Scientific   Multiscan   EX   Type   355 
spectrophotometer (Shanghai, China).
Polyclonal and Monoclonal Antibodies
Anti HBV polyclonal antibody is produced 
locally (West Nusa Tenggara Hepatitis, WNTH 
Laboratory). It was derived from hyperimmune 
sera of adult local  Equus caballus  (Sumba and 
Lombok female horses) which multi- immunized 
with   hepatitis   B   surface   antigens   (HBsAg) 
according to Mulyanto (1991). The  polyclonal 
antibody was a gift from Prof. Mulyanto and used 
as the main material to develop the conjugate. The 
monoclonal antibody (WNTH Laboratory Lot No. 
KO436) which is anti “a” determinant specific to 
HBsAg was also a courtesy of Prof. Mulyanto. 
The antibody was used for coating the ELISA 
plates. 
ELISA Kit Commercial
ELISA  Kit  commercial  used as a  ‘gold’ 
standard   throughout   this   study   was   Wantai 
HBsAg ELISA Kit (Wantai, China). 
Conjugate Preparation
Conjugate   was   prepared   for   three   days 
continuously by coupling HRP-aldehyde solution 
with horse-anti HBsAg polyclonal antibody based 
on   Nakane   and   Kawaoi   (1974)   with   slight 
modifications.   On   day   one,   HRP-aldehyde 
solution was prepared by dissolving a 5 mg of 
HRP into 1.0 ml freshly made of 0.3 M sodium 
bicarbonate, pH 8.1. In to this solution, 0.1 ml of 
FDNB   (1-fluoro-2,4-dinitrobenzene)   in 
absolute  ethanol  was   added,   and  then  mixed 
gently for 1 hr at room temperature. Subsequently 
1.0 ml of 0.08 M  NaI04  was added and mixed 
gently for 30 min at room temperature. Following 
this, 1.0 ml of 0.16 M ethylene glycol was added, 
mixed gently for 1 hr at room temperature, and 
dialyzed against three 1-liter changes of 0.01 M 
sodium carbonate buffer, pH 9.5, at 4°C. 
After the dialysis, a 5 mg of horse anti 
HBsAg-IgG was added to 3 mL of HRP-aldehyde 
solution  and mixed  gently  for   3  hr   at  room 
temperature. After that, 5 mg of NaBH4  was 
added and let stand for 3 hr at room temperature, 
then dialyzed at 4°C against PBS overnight. 
Finally,   the   solution   was   purified   by 
applying the solution to a 60 x 1.5 cm Sephacryl-
200 HR column (Pharmacia, Sweden) equilibrated 
in PBS and the absorbance of the fractions was 
read at 280 nm. The main peak fractions was 
pooled and designated as HRP labeled horse-anti 
HBsAg IgG polyclonal antibody and used for 
conjugate of the in-house HBsAg ELISA. 
ELISA Plates Preparation
ELISA plates were prepared by a standard 
procedure by coating the wells with 5µg/mL of 
mouse-anti   HBsAg   monoclonal   antibody   in 
carbonate buffer pH 9.5 at 100 µL per well and 
left  overnight  at 4°C.  Afterward,   plates  were 
blocked with 1% BSA-PBS, 300 µL/well for 3 h 
at room temperature and washed 3 times with 
PBS   containing   0.05%   Tween   20   (PBS-T). 
Following washing, plates were dried and kept in 
a foil sachet with desiccate gel. The plates were 
stored in 4°C until used.
Conjugate Tests
The principle of conjugate test that had been 
developed from horse serum in this study was 
based on immunological reactions between the 
primary antibody coated to the plate and the 
antigen in the sample, and then the reaction to the 
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(low, medium, and high) concentrations of in-
house HBsAg positive or negative standards were 
added into each well of plates coated with the 
primary antibody. Furthermore into the respective 
wells were added 50 µL of conjugate. The plate 
was then sealed and incubated for 60 min at 37ºC. 
After incubation, the plate was washed with a 
washing solution of 300 µL per well. Washing 
was performed  5 times,  and  50 µL  of TMB 
substrate was added into each well subsequently. 
Following incubation for 15 min in a dark room at 
37ºC, the reaction was stopped by adding 50 µL 
of 1 N sulfuric acid into the respective wells. The 
reaction   was   then   read   using   an   ELISA 
photoreader   at   a   450   nm   wavelength. 
Comparisons are performed simultaneously using 
a commercial ELISA Kit HBsAg. In addition, 
comparative   test   was   also   conducted   by   an 
independent  laboratory with a  commercial kit 
using a known concentration of HBsAg standard 
to obtain as objective result as possible. The 
HBsAg concentrations used were 0, 1.24, 5.43, 
24.10, 107 and 465 IU/mL. 
Data Analysis
The   data   obtained   were   compared 
descriptively to give an idea of the quality of 
conjugated   antibody   produced   in   this   study. 
Quantitative data regarding the ELISA tests were 
tabulated and analyzed according to Drouet et al. 
(2003), and Depamede and Kisworo (2011).
RESULTS AND DISCUSSION
Based on historical records, the horse has 
long   been   used   for   research   in   the   field   of 
immunology. Even since scientists have not been 
able   to   discover   about   the   antigen-antibody 
reactions, Emil von Behring had successfully used 
horse serum as a serum therapy for diphtheria 
(Stiehm and Johnston, 2005; Raju, 2006, Simon, 
2007). Nowadays horses still been used for serum 
therapy purposes (Bunning et al., 2002; de Cuetos 
et al., 2011), and for diagnostic development such 
as diagnostic for HBsAg. In this study the purified 
polyclonal  antibody   produced   in   local  horses 
using   HBsAg   of   Indonesia   origin   (Mulyanto, 
1991) was used to make conjugates for HBsAg 
ELISA. Preparation of the conjugates includes 
several steps such as binding of HRP enzyme as a 
marker onto the polyclonal antibodies. Following 
the binding, the conjugate was purified by means 
of size-exlusion column method. In the present 
study the binding and purification methods were 
performed   by   using   the   classical   method 
according to Nakane and Kawaoi (1974) with 
some modifications, and a representative result is 
presented in Figure 1. The main peak (fractions 
from minute 55 to minute 75) is the image of the 
binding reaction between the antibody and the 
HRP enzyme.  The  pooled   fractions   was  then 
defined as the in-house conjugate and used in 
subsequent experiments.
To   find   out   whether   the   developed 
conjugates could be used as a reagent to detect 
HBsAg,   the  conjugates  were  tested  against  a 
negative   and   three   defined   in-house   positive 
standard samples. The test results are shown in 
Figure 2. It can be seen in Figure 2 that the 
conjugates   produced   in   this   study   gave 
comparable results to existing commercial kits (P 
>0.05). Furthermore, test results carried out by an 
anonymous independent laboratory (Figure 3) was 
also revealed that the conjugates produced in this 
study have a comparable quality to that of the 
commercial   conjugate   against   known 
concentration   of   HBsAg   standards   used   to 
perform the comparison tests. Pattern of curves 
presented in Figures 2 and 3 are in agreement 
with the results of Karakus et al. (2007).
According to Gerritse  et  al.  (1991),  key 
points to consider when developing a conjugate is 
process itself should not affect the activity of 
enzymes and antibodies used. The results of the 
present study indicated that the conjugate (pooled 
fractions of the main peak, Figure 1) provides 
immunological and enzymatic reactions that are 
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Figure 1. Representation of Chromatogram of 5 mg 
Horse Anti HBsAg IgG Conjugated with 5 mg 
HRP Activated by 0.08 M NaIO4 as Modified from 
Nakane and Kawaoi (1974) 
uV
Minequivalent to a similar reaction on a commercial 
conjugate   (Figure   2).   Furthermore,   the 
independent test results as shown in Figure 3 
reinforced that the conjugates produced in this 
study gave reliable results. Even so, when it was 
seen in Figures 2 and 3 there was a tendency that 
the   conjugates   produced   in  this   study   (filled 
circles) was still below the commercial conjugate 
(open circles). Shin and Heo (2000) asserted that 
in  addition  to sensitivity and specificity of a 
diagnostic kit, the other values that need to also 
consider is detection limit and its reproducibility. 
For those reasons, the results of the present study 
still need to be followed up further.
Overall   these   results   suggest   that   the 
antibodies produced by utilizing the local horses 
to develop the conjugate ELISA, can provide 
comparable results to conjugates that available 
commercially.
Utilization of Indonesia germ plasma is very 
important, especially in the efforts to develop 
vaccines and immunodiagnostics such as against 
HBV,   especially   to   improve   the   immune 
specificity of the vaccine or the kit. Recently it 
has been reported that in Indonesia some new 
HBV genotypes have been elucidated (Lusida et 
al.,  2008, Mulyanto  et al.,  2009, 2010, 2011, 
2012). This means that efforts to prevent the 
spread   of   HBV   in   Indonesia   will   be   more 
effective if we can provide the components to 
develop diagnostic kits derives from the local 
germ  plasma.   This   should   become   a   serious 
concern for Indonesia with a population of more 
than 200 million people with the HBV carrier 
rates are 4-20.3% (Khan et al., 2004; Mulyanto et 
al., 2008).
CONCLUSION 
This study shows that antibody generated 
using the local horses can be utilized to develop 
test   kit   against   infectious   diseases   such   as 
Hepatitis B with feasible results. However, further 
studies are still required to improve it sensitivity, 
specificity, reproducibility and stability as needed 
by a diagnostic kit.
ACKNOWLEDGMENTS
The authors wish to thank Prof.  Mulyanto, 
Director of West Nusa Tenggara (WNT) Hepatitis 
Laboratory-Indonesia, for his supports especially 
for the antibodies and reagents used throughout 
this study. The authors also thanks Mr. Hulaimi of 
WNT Hepatitis Laboratory, and Mr. Suparman, 
staff at the Immunobiology Laboratory of Faculty 
of Mathematics and Natural Sciences, Mataram 
University, for their technical assistances.
REFERENCES
Bunning, M.L., R.A. Bowen, C.B. Cropp, K.G. 
Sullivan, B.S. Davis, N. Komar, M.S. Godsey, 
D.  Baker,  D.L.  Hettler,  D.A.  Holmes,  B.J. 
Biggerstaff,   and   C.J.   Mitchell.   2002. 
Experimental infection of horses with West 
Nile virus. Emerging infectious diseases. 8(4): 
380-386.
106 J.Indonesian Trop.Anim.Agric. 37(2) June 2012
Figure 2. Comparison between Conjugate of this 
Study  (:LH)  and  a Commercial Conjugate  (: 
Wantai)   against   Various   Concentration   of 
Homemade (in-house) HBsAg Standards
Figure 3. Comparison between Conjugate of this 
study   (:LH)   and   Anonymous   Conjugate 
(:Anonym) against Various Concentration (0, 1.24, 
5.43,   24.10,   107   and   465   IU/ml)  of   HBsAg 
Standards,   Conducted   by   an   Independent 
Laboratoryde Cuetos, E.E.V., R.A. Fernandez, M.I. Bianco, 
O.J. Sartori, M.L. Piovano, C. Lúquez, and 
L.I.T.   de   Jong.   2011.   Equine   botulinum 
antitoxin for the treatment of infant botulism. 
Clin. Vaccine Immunol. 18(11):1845-1849
Depamede,   S.N.   and   D.   Kisworo.   2011. 
Development   of   enzyme-linkage 
immunosorbent   assay   against   type   B   of 
Clostridium botulinum: A preliminary study. 
J.Indonesian Trop.Anim.Agric. 36(4):237-242
Drouet, C., M-F. Nissou, D. Ponard, J. Arvieux, C. 
Dumestre-Perard,   P.   Gaudin,   B.   Imbert,   C. 
Massot   and   F.   Sarrot-Reynauld.   2003. 
Detection of anti endothelial cell antibodies by 
an enzyme-linked immunosorbent assay using 
antigens from cell lysate: Minimal interference 
with  antinuclear   antibodies   and   rheumatoid 
factors. Clin. Diagn. Lab. Immunol. 10:934-
939
Gerritse, K., M. Fasbender, W. Boersma and E. 
Claassen.  1991.  Conjugate formation in urea: 
coupling   of   insoluble   peptides   to   alkaline 
phosphatase for ELISA and in situ detection of 
antibody-forming   cells.   J.   Histochem. 
Cytochem. 39(7):987-992
Karakus, R., L.A. Aral, B. Basturk and C. Abay. 
2007.   Development   of   a   Highly   Sensitive 
ELISA for Quantification of Hepatitis B Virus 
(HBV) Surface Antigen (HBsAg). Turkey J. 
Medical Sci. 37(2): 87-92
Khan,   M.,   J.J.   Dong,   S.K.   Acharya,   Y. 
Dhagwahdorj, Z. Abbas, S.M.W. Jafri, D.H. 
Mulyono,   N.  Tozun  and  S.K.   Sarin.  2004. 
Hepatology issues in Asia: Perspectives from 
regional   leaders.   J.   Gastroenterology   and 
Hepatology. 19:S419–S430
Lee, W.M., 1997. Hepatitis B virus infection. N. 
Engl. J. Med. 337 (24): 1733–1745
Lusida,  M.I.,  V.E.  Nugrahaputra,  Soetjipto,  R. 
Handajani, M. Nagano-Fujii, M., Sasayama, T. 
Utsumi   and   H.   Hotta.   2008.   Novel 
subgenotypes of hepatitis B virus genotypes C 
and D in Papua, Indonesia. J. Clin. Microbiol. 
46(7):2160–2166
Markel, H. 2007. Long Ago Against Diphtheria, 
the Heroes Were Horses. The New York Times, 
July   2007.   http://www.nytimes. 
com/2007/07/10/health/10hors.html?_r=1
Mulyanto,   K.   Surayah,   S.N.   Depamede,   I.A. 
Lestarini, W. Budianto, Hafiludin, K. Umi, F. 
Tsuda, M. Takahashi and H, Okamoto. 2008. 
Hepatitis B virus infection in Eastern part of 
Indonesia.   Abstract,   Book   of   the   Second 
China-Indonesia   Joint   International 
Symposium  on  Hepatobiliary Medicine and 
Surgery, Chongqing, China.
Mulyanto, P. Pancawardani, S.N. Depamede, A. 
Wahyono,   S.   Jirintai,   S.   Nagashima,   M. 
Takahashi,   T.   Nishizawa   and   H.   Okamoto. 
2012. Identification of four novel subgenotypes 
(C13–C16)   and   two   inter-genotypic 
recombinants (C12/G and C13/B3) of hepatitis 
B virus in Papua Province, Indonesia. Virus 
Res. 163: 129-140
Mulyanto, S.N. Depamede, A. Wahyono, Jirintai, 
S. Nagashima, M. Takahashi and H. Okamoto. 
2011. Analysis of the full-length genomes of 
novel hepatitis B virus subgenotypes C11 and 
C12 in Papua, Indonesia. J. Med. Virol. 83(1): 
54-64
Mulyanto,   S.N.   Depamede,   K.   Surayah,  A.A. 
Tjahyono,   Jirintai,   S.   Nagashima,   M. 
Takahashi   and   H.   Okamoto.   2010. 
Identification   and   characterization   of   novel 
hepatitis B virus subgenotype C10 in Nusa 
Tenggara, Indonesia. Arch. Virol. 155(5):705-
715
Mulyanto, S.N. Depamede, K. Surayah, F. Tsuda, 
K. Ichiyama, M. Takahashi, H. Okamoto. 2009. 
A nationwide molecular epidemiological study 
on hepatitis B virus in Indonesia: identification 
of two novel subgenotypes, B8 and C7. Arch. 
Virol. 154 (7):1047–1059.
Mulyanto.   1991.   Perbedaan   Imunogenisitas 
Hepatitis   B   surface   antigen   (HBsAg)   dari 
berbagai Subtipe, Studi Seroepidemiologik dan 
Laboratorik dalam rangka Pemurnian HBsAg. 
Dissertation.   Fakultas   Pasca   Sarjana. 
Universitas Airlangga. Indonesia.
Nakane, P.L., and A. Kawaoi. 1974. Peroxidase-
labeled antibody a new method of conjugation. 
J. Histo. Chem. 22(12):1084-1091
Shin, H-S., and T-R. Heo. 2000. Evaluation of 
rapid immunochromatographic assay kit for 
HBsAg-screening   using   whole   blood. 
Biotechnol. Bioprocess Eng. 5: 362-365.
Simon, J. 2007. Emil Behring’s medical culture: 
From   disinfection   to   serotherapy.   Medical 
History 51:201-218
Stiehm, E.R., and R.B. Johnston. 2005. A history 
of pediatric immunology. Pediatric Research 
57: 458-467.
Zuckerman,   J.N.   and  A.J.   Zuckerman.   2000. 
Current topics in hepatitis B. J Infect. 41:130-
136. 
Utilization Antibodies Produced in Local Equus caballus  (S.N. Depamede et al.) 107